German China

Covid-19 Test Bio-Rad Launches Sars-Cov-2 RT-PCR Assay Kit in Europe

Editor: MA Alexander Stark

Bio-Rad Laboratories announced the launch of the Reliance Sars-Cov-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.

Related Vendors

The Reliance Sars-Cov-2 RT-PCR Kit (IVD) is designed for clinical diagnostic labs that conduct Covid-19 testing.
The Reliance Sars-Cov-2 RT-PCR Kit (IVD) is designed for clinical diagnostic labs that conduct Covid-19 testing.
(Source: Bio-Rad)

Hercules/USA — The Reliance Sars-Cov-2 RT-PCR Kit from Bio-Rad is a real-time reverse-transcription PCR (RT-PCR) test that can detect nucleic acid in Sars-Cov-2, the virus associated with Covid-19 disease. The kit has now been made available in Europe. A version of the assay kit is also available in the United States under an U.S. Food and Drug Administration (FDA) emergency use authorization (EUA).

The Reliance Sars-Cov-2 RT-PCR Kit (IVD) is designed for clinical diagnostic labs that conduct Covid-19 testing. The assay kit offers the qualitative detection of two separate target regions in the nucleocapsid gene (N1 and N2 regions) of Sars-Cov-2 in nasopharyngeal swab specimens from individuals suspected of being infected by Covid-19. Because they are designed to target the nucleocapsid gene, the assay’s performance is not affected by known coronavirus variants as determined by in-silico analysis. The assay kit contains Bio-Rad’s standard and negative molecular controls as well as assay reagents, and it is validated to run on Bio-Rad’s CFX96 Dx RT-PCR system, as well as RT-PCR systems from other manufacturers.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:47401542)